FY 2026 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts.
2025 · 4th Quarter (Oct 1 - Dec 31)
AMERICAN ASSOCIATION FOR CANCER RESEARCH
Filed by AMERICAN ASSOCIATION FOR CANCER RESEARCH.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 16, 2026
- Income
- Not reported
- Expenses
- $100,000.00
- Registrant
- AMERICAN ASSOCIATION FOR CANCER RESEARCH
- Filing UUID
- 44a0c2cf-e748-4227-b6cd-dca52bca6480
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Cancer research generally Diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention
Tobacco control and prevention Tobacco cessation
Reducing cancer disparities Cancer survivorship Preventing HPV-related cancers
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.